Mechanism of evasion of cyclic oligonucleotide-based anti-phage signaling system
- Institution
- TUFTS UNIVERSITY BOSTON, MA
- Principal investigator
- Wai-Leung Ng
- Funding
- $454K
- Duration
- 2025–2027
Moonbase score
Still being scored
Abstract
Project Summary Bacteriophages (Phages) are viruses that attack bacteria. Not only are phages valuable resources for novel biotechnological and molecular biology tools, but they can also be used in clinical settings for treating antibiotic-resistant infections. Bacteria carry many mechanisms to defend against phage infection and, in turn, phages have acquired counter-defense mechanisms to evade the protection. Many of these defense and counter-defense systems have counterparts in the eukaryotic innate immune systems. Therefore, understanding the arms race between the phages and their bacterial hosts is important for future development of phage therapy and other antiviral strategies. Here we will study how some phages evade the protection offered by a specific phage defense system present in many bacteria including some deadly pathogens. Specifically, we have identified a phage protein that antagonizes an antiviral system in the human pathogen Vibrio cholerae and other important pathogens. We will determine the counter-defense mechanism of this phage protein, and we will identify the role of this phage protein during phage infection. The investigation proposed here will not only inform the molecular mechanism of this arms race, but we will learn how phage-bacteria interaction shapes the evolution of a deadly pathogen. Our findings could have significant ramifications for improving human health.
LOADING MOONBASE SCORE
Questions for TUFTS UNIVERSITY BOSTON
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Tufts University BostonNot yet scored
Signaling Mechanisms in Vibrio Cholerae Parallel Quorum Sensing Pathways
Wai-Leung Ng · $465K · 2015–2026
- NIH · Tufts University Boston62
Integrating point-of-care urine isoniazid testing into routine care for tuberculosis disease in India to detect medication nonadherence and improve treatment outcomes
Ramnath Subbaraman · $451K · 2025–2030
- NIH · Tufts University Boston48
Dysfunctional Astroglial Exosome to (motor) Neuron Axon Signaling in ALS
Yongjie Yang · $381K · 2022–2027